Picture of HUTCHMED (China) logo

HCM HUTCHMED (China) Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual income statement for HUTCHMED (China), fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue205228356426838
Cost of Revenue
Gross Profit44.739.597.9115454
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses351425563834825
Operating Profit-146-197-207-40812.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-100-111-155-361106
Provision for Income Taxes
Net Income After Taxes-104-116-167-360101
Minority Interest
Net Income Before Extraordinary Items
Net Income-106-126-195-361101
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-106-126-195-361101
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.159-0.18-0.246-0.4260.122